Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peng Zhan

Showing results (61-70 of 558) with videos related to

Pageof 56
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 26, 2025
Nucleoside antiviral agents with atypical structures and new targetsHui Xu, Baohu Li, Kai Tang, et al.
European Journal of Medicinal Chemistry|November 29, 2024
Recent advances in screening methods enabling the discovery of novel anti-hepatitis B virus drug candidatesYu Jin, Shuo Wang, Kai Tang, et al.
Biochemical Pharmacology|October 3, 2024
PCSK9 inhibitor attenuates cardiac fibrosis in reperfusion injury rat by suppressing inflammatory response and TGF-β1/Smad3 pathwayQing Huang, Zhina Zhou, Lei Xu, et al.
Polymers|June 28, 2023
Design and Synthesis of Porous Organic Polymers: Promising Catalysts for Lignocellulose Conversion to 5-Hydroxymethylfurfural and DerivatesLei Yang, Lishu Shao, Zhiping Wu, et al.
Current Pharmaceutical Design|May 25, 2012
The development of HEPT-type HIV non-nucleoside reverse transcriptase inhibitors and its implications for DABO familyWenmin Chen, Peng Zhan, Jingde Wu, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2025
Privileged scaffold repurposed: the evolving role of quinolone derivatives in antiviral therapyHui Xu, Baohu Li, Kai Tang, et al.
The Lancet Regional Health. Western Pacific|November 24, 2022
Trends and projections of universal health coverage indicators in China, 1993-2030: An analysis of data from four nationwide household surveysYuanyuan Li, Chunfeng Zhang, Peng Zhan, et al.
Drug Discovery Today|January 18, 2018
Influenza A virus polymerase: an attractive target for next-generation anti-influenza therapeuticsZhongxia Zhou, Tao Liu, Jian Zhang, et al.
Molecular Biosystems|September 12, 2014
Recent advances in the structure-based rational design of TNKSIsPeng Zhan, Yu'ning Song, Yukihiro Itoh, et al.
Future Medicinal Chemistry|March 10, 2026
Overview of recent strategic advances in antiviral covalent inhibitorsBo Wang, Siyuan Wang, Jiwei Zhang, et al.
Pageof 56

Showing results (61-70 of 558) with videos related to

Sort By:
Pageof 56
Bioorganic & Medicinal Chemistry Letters|January 26, 2025
Nucleoside antiviral agents with atypical structures and new targetsHui Xu, Baohu Li, Kai Tang, et al.
European Journal of Medicinal Chemistry|November 29, 2024
Recent advances in screening methods enabling the discovery of novel anti-hepatitis B virus drug candidatesYu Jin, Shuo Wang, Kai Tang, et al.
Biochemical Pharmacology|October 3, 2024
PCSK9 inhibitor attenuates cardiac fibrosis in reperfusion injury rat by suppressing inflammatory response and TGF-β1/Smad3 pathwayQing Huang, Zhina Zhou, Lei Xu, et al.
Polymers|June 28, 2023
Design and Synthesis of Porous Organic Polymers: Promising Catalysts for Lignocellulose Conversion to 5-Hydroxymethylfurfural and DerivatesLei Yang, Lishu Shao, Zhiping Wu, et al.
Current Pharmaceutical Design|May 25, 2012
The development of HEPT-type HIV non-nucleoside reverse transcriptase inhibitors and its implications for DABO familyWenmin Chen, Peng Zhan, Jingde Wu, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2025
Privileged scaffold repurposed: the evolving role of quinolone derivatives in antiviral therapyHui Xu, Baohu Li, Kai Tang, et al.
The Lancet Regional Health. Western Pacific|November 24, 2022
Trends and projections of universal health coverage indicators in China, 1993-2030: An analysis of data from four nationwide household surveysYuanyuan Li, Chunfeng Zhang, Peng Zhan, et al.
Drug Discovery Today|January 18, 2018
Influenza A virus polymerase: an attractive target for next-generation anti-influenza therapeuticsZhongxia Zhou, Tao Liu, Jian Zhang, et al.
Molecular Biosystems|September 12, 2014
Recent advances in the structure-based rational design of TNKSIsPeng Zhan, Yu'ning Song, Yukihiro Itoh, et al.
Future Medicinal Chemistry|March 10, 2026
Overview of recent strategic advances in antiviral covalent inhibitorsBo Wang, Siyuan Wang, Jiwei Zhang, et al.
Pageof 56